CYTOMEGALOVIRUS ISOLATE RESISTANT TO GANCICLOVIR AND FOSCARNET FROM A MARROW TRANSPLANT PATIENT

被引：92
作者：
KNOX, KK
DROBYSKI, WR
CARRIGAN, DR
机构：
[1] MED COLL WISCONSIN,DEPT MED,MILWAUKEE,WI 53226
[2] MED COLL WISCONSIN,BONE MARROW TRANSPLANT PROGRAM,MILWAUKEE,WI 53226
来源：
LANCET | 1991年 / 337卷 / 8752期
关键词：
D O I：
10.1016/0140-6736(91)92965-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1292 / 1293
页数：2
相关论文
共 9 条
[1]  
BIRCH CJ, 1989, J INFECT DIS, V162, P731
[2]  
DERSE D, 1982, J BIOL CHEM, V257, P251
[3]  
DROBYSKI WR, IN PRESS TRANSPLANTA
[4]   PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS [J].
ERICE, A ;
CHOU, S ;
BIRON, KK ;
STANAT, SC ;
BALFOUR, HH ;
JORDAN, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :289-293
[5]  
FRANK KB, 1982, ANTIMICROB AGENTS CH, V27, P445
[6]   INCREASED EFFICACY OF GANCICLOVIR IN COMBINATION WITH FOSCARNET AGAINST CYTOMEGALOVIRUS AND HERPES-SIMPLEX VIRUS TYPE-2 INVITRO AND INVIVO [J].
FREITAS, VR ;
FRASERSMITH, EB ;
MATTHEWS, TR .
ANTIVIRAL RESEARCH, 1989, 12 (04) :205-212
[7]   HIV WITH REDUCED SENSITIVITY TO ZIDOVUDINE (AZT) ISOLATED DURING PROLONGED THERAPY [J].
LARDER, BA ;
DARBY, G ;
RICHMAN, DD .
SCIENCE, 1989, 243 (4899) :1731-1734
[8]   SYNERGISTIC EFFECT OF GANCICLOVIR AND FOSCARNET ON CYTOMEGALOVIRUS REPLICATION INVITRO [J].
MANISCHEWITZ, JF ;
QUINNAN, GV ;
LANE, HC ;
WITTEK, AE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :373-375
[9]  
PARKER AC, 1987, LANCET, V2, P1461
1